Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-25-056816
Filing Date
2025-06-05
Accepted
2025-06-05 15:58:16
Documents
2
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2517275d1_6k.htm 6-K 119124
2 GRAPHIC tm2517275d1_6kimg001.jpg GRAPHIC 17086
  Complete submission text file 0001104659-25-056816.txt   143796
Mailing Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036
Business Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036 212-969-3335
Grifols SA (Filer) CIK: 0001438569 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35193 | Film No.: 251026977
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)